Advertisement

Advertisement

Most Viewed Videos
William J. Gradishar, MD, on HR-Positive, HER2-Negative Advanced Breast Cancer: NCCN Guidelines Updates
Frederick L. Locke, MD, on Innovative CAR-T Cell Therapies: The Patient Experience
Leora Horn, MD, on Small Cell Lung Cancer and Immuno-oncology: Have We Finally Solved the Small Cell Paradox?
Shraddha M. Dalwadi, MD, MBA, on Non–Small Cell Lung Cancer: What Contributes to Disparities in Treating Stage I Disease
Robert A. Figlin, MD, on RCC: Results From the ADAPT Trial
Karim Fizazi, MD, PhD: We Need to Find a Way to Make Cancer Drugs Affordable
Ruqin Chen, MB, on Lung Cancer Treated With Immune Checkpoint Inhibitors: Survival Outcomes and Clinical and Molecular Features
Heather A. Wakelee, MD, on Advanced Non–Small Cell Lung Cancer: State-of-the-Art Treatment for EGFR-Positive and ALK-Positive Diseases
Sumanta K. Pal, MD: Let's Get More Patients With Rare Tumors Into Clinical Trials
Martin Edelman, MD, on Immunotherapy: How Safe Is It for Patients With Autoimmune Disease?
Matthew A. Gubens, MD, on Non–Small Cell Lung Cancer: New Immunotherapy Strategies in the NCCN Guidelines
J. Fletcher Drogos, MD, on Multiple Courses of Stereotactic Body Radiation Therapy: Outcomes in Patients With Lung Cancer
Aaron S. Mansfield, MD, on Treating Rare Thoracic Cancers: Status Update
Eric Jonasch, MD, on Kidney Cancer: A Year in Review
Mark K. Ferguson, MD, on Mitigating Frailty and Sarcopenia to Improve Treatment Outcomes
Jedd D. Wolchok, MD, PhD, on The Future of Immunotherapy: Keynote Lecture
Kyle F. Concannon, MD, on Lung Cancer in Homeless Patients: Outcomes and Quality Measures
Melinda L. Telli, MD, on NCCN Guidelines Updates for HR-Positive, HER2-Negative Early-Stage Breast Cancer
Bruce D. Cheson, MD, and Richard I. Fisher, MD, on Lymphoma: Treatment Considerations
Stage III Non–Small Cell Lung Cancer: A Look at New Systemic Treatments

Advertisement

Advertisement



;
Advertisement